¼¼°èÀÇ »ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­ ½ÃÀå
Biological Data Visualization
»óǰÄÚµå : 1766919
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 381 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,222,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,666,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

»ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 21¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 13¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â »ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 7.8%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 21¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®µÇ°í ÀÖ´Â ºÎ¹® Áß ÇϳªÀÎ ½ÃÄö½ÌÀº CAGR 7.9%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 8¾ï 1,450¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Çö¹Ì°æ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 7.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3¾ï 4,320¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 11.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ »ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­ ½ÃÀåÀº 2024³â¿¡´Â 3¾ï 4,320¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2024³âºÎÅÍ 2030³â ºÐ¼® ±â°£ µ¿¾È CAGR 11.9%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 5¾ï 3,660¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 3.4%¿Í 6.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è »ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

±â¼ú Çõ½ÅÀº »ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­¸¦ ¾î¶»°Ô º¯È­½Ãų °ÍÀΰ¡?

µ¥ÀÌÅÍ ºÐ¼® ¹× ½Ã°¢È­ µµ±¸ÀÇ ±â¼ú ¹ßÀüÀº »ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­ ½ÃÀå¿¡ Çõ¸íÀ» °¡Á®¿ÔÀ¸¸ç, ¿¬±¸ÀÚµéÀº º¹ÀâÇÑ µ¥ÀÌÅͼ¼Æ®¸¦ º¸´Ù Á¤È®ÇÏ°í ºü¸£°Ô ÇØ¼®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. »ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­´Â À¯ÀüÀÚ ¼­¿­, ´Ü¹éÁú ±¸Á¶, ºÐÀÚ°£ »óÈ£ÀÛ¿ë µî »ý¹°ÇÐÀû µ¥ÀÌÅ͸¦ ±×·¡ÇÈÀ¸·Î Ç¥ÇöÇÏ¿© »ý¹°ÇÐÀû °úÁ¤°ú Áúº´ ¸ÞÄ¿´ÏÁò¿¡ ´ëÇÑ ÀÌÇØ¸¦ µ½½À´Ï´Ù. ÃÖ±Ù ºòµ¥ÀÌÅÍ ºÐ¼®, ÀΰøÁö´É(AI), ¸Ó½Å·¯´×(ML) ºÐ¾ßÀÇ ±â¼ú Çõ½ÅÀº ´ë·®ÀÇ »ý¹°ÇÐÀû µ¥ÀÌÅ͸¦ ó¸®Çϰí ÀÇ¹Ì ÀÖ´Â ½Ã°¢Àû ÀλçÀÌÆ®¸¦ âÃâÇÏ´Â ´É·ÂÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. °í¼º´É ÄÄÇ»ÆÃ(HPC) Ç÷§Æû°ú Ŭ¶ó¿ìµå ±â¹Ý ½Ã°¢È­ µµ±¸´Â »ý¹°ÇÐÀû µ¥ÀÌÅÍ ºÐ¼®ÀÇ Á¢±Ù¼º°ú È®À强À» ´õ¿í Çâ»ó½ÃÄÑ ¿¬±¸ÀÚµéÀÌ Àü ¼¼°è ÇÁ·ÎÁ§Æ®¿¡¼­ ½Ç½Ã°£À¸·Î Çù¾÷ÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ ½Ã°¢È­ ¼ÒÇÁÆ®¿þ¾î¿¡ AI ±â¹Ý ¾Ë°í¸®ÁòÀÌ ÅëÇյǾî ÀÚµ¿ ÆÐÅÏ ÀÎ½Ä ¹× ¿¹Ãø ¸ðµ¨¸µÀÌ °¡´ÉÇØÁü¿¡ µû¶ó ¿¬±¸ÀÚµéÀº Áß¿äÇÑ »ý¹°ÇÐÀû µ¿Çâ°ú °ü°è¸¦ º¸´Ù ºü¸£°Ô ÆÄ¾ÇÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº °úÇÐÀÚµéÀÌ »ý¹°ÇÐÀû µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ´Â ¹æ½ÄÀ» º¯È­½ÃÄÑ º¸´Ù Á¤È®Çϰí È¿À²ÀûÀÎ ½Å¾à °³¹ß, À¯Àüü ¿¬±¸, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ³ë·ÂÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

»ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­°¡ »ý¸í°úÇп¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀϱî?

ÃֽŠ¿¬±¸ ±â¼ú·Î ÀÎÇØ µ¥ÀÌÅÍÀÇ ¾ç°ú º¹À⼺ÀÌ ±âÇϱ޼öÀûÀ¸·Î Áõ°¡Çϰí ÀÖ´Â »ý¸í°úÇÐ ºÐ¾ß¿¡¼­ »ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­´Â Á¡Á¡ ´õ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. À¯ÀüüÇÐ, ´Ü¹éÁúüÇÐ, ´ë»çüÇÐ ¿¬±¸ ¹× ½Å¾à°³¹ß ¿¬±¸¿¡¼­´Â ¹æ´ëÇÑ ¾çÀÇ µ¥ÀÌÅͰ¡ »ý¼ºµÇÁö¸¸, ÀÇ¹Ì ÀÖ´Â ÀλçÀÌÆ®¸¦ ¾ò±â À§Çؼ­´Â °íµµÀÇ ½Ã°¢È­ ±â¼úÀÌ ÇÊ¿äÇÕ´Ï´Ù. º¹ÀâÇÑ »ý¹°ÇÐÀû µ¥ÀÌÅ͸¦ ±×·¡ÇÈ Çü½ÄÀ¸·Î Ç¥ÇöÇÔÀ¸·Î½á ¿¬±¸ÀÚµéÀº ½Ã°¢È­ µµ±¸¸¦ ÅëÇØ ¿ø½Ã µ¥ÀÌÅ͸¸À¸·Î´Â ¹ß°ßÇϱ⠾î·Á¿î ÆÐÅÏ, °ü°è, ÀÌ»óÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ´Â À¯ÀüÀÚ ¼­¿­À» ¸ÅÇÎÇÏ°í ºñ±³ÇÏ´Â µ¥ ½Ã°¢Àû µµ±¸°¡ »ç¿ëµÇ´Â À¯ÀüüÇÐÀ̳ª ´Ü¹éÁúÀÇ ±¸Á¶¿Í »óÈ£ÀÛ¿ëÀ» ½Ã°¢È­ÇÒ ¼ö ÀÖ´Â ´Ü¹éÁúüÇÐ ºÐ¾ß¿¡¼­ ƯÈ÷ Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ, »ý¹°ÇÐÀû µ¥ÀÌÅÍÀÇ ½Ã°¢È­´Â ¸ÂÃãÇü ÀÇ·áÀÇ ¹ßÀü¿¡µµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. °³º° À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ¿¡ ¸Â´Â Ä¡·á¸¦ Çϱâ À§Çؼ­´Â ȯÀÚº° µ¥ÀÌÅ͸¦ ºÐ¼®ÇØ¾ß ÇÕ´Ï´Ù. »ý¸í°úÇÐ ºÐ¾ßÀÇ ¹ßÀü°ú ÇÔ²² »ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­´Â »õ·Î¿î ¹ß°ßÀ» À̲ø¾î³»°í °úÇÐÀÇ Áøº¸¸¦ °¡¼ÓÈ­ÇÏ´Â µ¥ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

»ê¾÷°ú ÇコÄɾîÀÇ µ¿ÇâÀº »ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­ ½ÃÀåÀ» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

»ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­ ½ÃÀåÀº ÇコÄÉ¾î ¹× »ý¸í°úÇÐ »ê¾÷ÀÇ ¸î °¡Áö ÁÖ¿ä Æ®·»µå, ƯÈ÷ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡¿Í ¸ÖƼ¿À¹Í½º ¿¬±¸ÀÇ ºÎ»óÀ¸·Î ÀÎÇØ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·á°¡ °è¼Ó È®»êµÊ¿¡ µû¶ó Á¤±³ÇÑ µ¥ÀÌÅÍ ½Ã°¢È­ µµ±¸ÀÇ Çʿ伺ÀÌ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. ¿¬±¸ °³¹ßÀÚ¿Í ÀÓ»óÀÇ´Â À¯Àüü ¼­¿­, ´Ü¹éÁúüÇÐ ÇÁ·ÎÆÄÀÏ, ÀÓ»ó ±â·Ï µî ´ë±Ô¸ðÀÇ º¹ÀâÇÑ µ¥ÀÌÅͼ¼Æ®¸¦ ºÐ¼®ÇÏ¿© °íÀ¯ÇÑ ¹ÙÀÌ¿À¸¶Ä¿¸¦ ½Äº°Çϰí, ȯÀÚ °³°³Àο¡ ¸Â´Â ¸ÂÃãÇü Ä¡·á¹ýÀ» °³¹ßÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ µ¥ÀÌÅÍ ±â¹Ý ¸ÂÃãÇü ÀÇ·á·ÎÀÇ ÀüȯÀº ȯÀÚº° µ¥ÀÌÅ͸¦ ó¸®Çϰí ÇØ¼®ÇÒ ¼ö ÀÖ´Â °í±Þ »ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À¯ÀüüÇÐ, ´Ü¹éÁúüÇÐ, Àü»çüÇÐ, ´ë»çüÇÐ µîÀÇ µ¥ÀÌÅ͸¦ ÅëÇÕÇÏ´Â ¸ÖƼ¿À¹Í½º Á¢±Ù¹ýÀÇ Ã¤ÅÃÀÌ È®´ëµÇ¸é¼­ »ý¹°ÇÐÀû µ¥ÀÌÅÍ ºÐ¼®ÀÇ º¹À⼺ÀÌ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ´ÙÃþÀûÀÎ µ¥ÀÌÅͼ¼Æ®¸¦ ÀϰüµÇ°í ÇØ¼® °¡´ÉÇÑ ¹æ½ÄÀ¸·Î ÅëÇÕÇϰí Ç¥½ÃÇÒ ¼ö ÀÖ´Â ½Ã°¢È­ µµ±¸´Â ¿¬±¸ ¹ßÀü°ú ÀÓ»ó °á°ú °³¼±¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

»ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀϱî?

»ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­ ½ÃÀåÀÇ ¼ºÀåÀº »ý¹°ÇÐÀû ¿¬±¸ÀÇ º¹À⼺, µ¥ÀÌÅÍ ºÐ¼®ÀÇ ±â¼úÀû Áøº¸, ¸ÂÃãÇü ÀÇ·áÀÇ ¿ªÇÒ È®´ë µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â À¯Àüü ¹× ¸ÖƼ¿À¹Í½º ¿¬±¸ÀÇ ±Þ°ÝÇÑ ¼ºÀåÀ¸·Î ºÐ¼®¿¡ °í±Þ ½Ã°¢È­ µµ±¸°¡ ÇÊ¿äÇÑ ¹æ´ëÇÑ ¾çÀÇ µ¥ÀÌÅͰ¡ »ý¼ºµÇ°í ÀÖÀ¸¸ç, AI¿Í ¸Ó½Å·¯´×ÀÇ ºÎ»óµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº µ¥ÀÌÅÍ ºÐ¼®°ú ÆÐÅÏ ÀνÄÀÇ ÀÚµ¿È­¸¦ °¡´ÉÇÏ°Ô Çϰí, ¿¬±¸ÀÚµéÀÌ º¹ÀâÇÑ »ý¹°ÇÐÀû µ¥ÀÌÅÍ¿¡¼­ ÀλçÀÌÆ®¸¦ ½±°Ô µµÃâÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÀÓ»óÀǰ¡ ȯÀÚº° µ¥ÀÌÅ͸¦ ÇØ¼®ÇÏ°í ¸ÂÃãÇü Ä¡·á °èȹÀ» ¼ö¸³ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ½Ã°¢È­ µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ°ú °í¼º´É ÄÄÇ»ÆÃ Ç÷§ÆûÀÇ È®ÀåÀº »ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­ ¼Ö·ç¼ÇÀÇ Á¢±Ù¼º°ú È®À强À» ´õ¿í Çâ»ó½ÃÄÑ ¿¬±¸ÀÚµéÀÌ ´ë±Ô¸ð ÇÁ·ÎÁ§Æ®¿¡¼­ °øµ¿ ÀÛ¾÷Çϰí Àü ¼¼°èÀûÀ¸·Î ¿¬±¸ °á°ú¸¦ °øÀ¯ÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. µ¥ÀÌÅÍ ±â¹Ý ¿¬±¸¿Í °³ÀÎÈ­µÈ ÇコÄɾ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó »ý¹°ÇÐÀû µ¥ÀÌÅÍ ½Ã°¢È­ ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÎ¹®

±â¼ú(½ÃÄö½Ì, Çö¹Ì°æ, ÀÚ±â°ø¸í¿µ»ó, X¼± °áÁ¤±¸Á¶ ºÐ¼®, ±âŸ ±â¼ú), ¿ëµµ(¼¼Æ÷¡¤»ý¹° À̹Ì¡, ±¸Á¶ »ý¹°ÇС¤ºÐÀÚ ¸ðµ¨¸µ, À¯Àüü ÇØ¼®, ¾ó¶óÀÎ¸ÕÆ®, °èÅ롤ÁøÈ­, ½Ã½ºÅÛ »ý¹°ÇÐ), ÃÖÁ¾ ¿ëµµ(Çмú ¿¬±¸, Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷, º´¿ø¡¤Å¬¸®´Ð, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Biological Data Visualization Market to Reach US$2.1 Billion by 2030

The global market for Biological Data Visualization estimated at US$1.3 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Sequencing, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$814.5 Million by the end of the analysis period. Growth in the Microscopy segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$343.2 Million While China is Forecast to Grow at 11.9% CAGR

The Biological Data Visualization market in the U.S. is estimated at US$343.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$536.6 Million by the year 2030 trailing a CAGR of 11.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Biological Data Visualization Market - Key Trends & Drivers Summarized

How Are Technological Innovations Transforming Biological Data Visualization?

Technological advancements in data analytics and visualization tools are revolutionizing the biological data visualization market, enabling researchers to interpret complex datasets with greater precision and speed. Biological data visualization involves the graphical representation of biological data, such as genetic sequences, protein structures, and molecular interactions, to enhance the understanding of biological processes and disease mechanisms. Recent innovations in big data analytics, artificial intelligence (AI), and machine learning (ML) are improving the ability to process large volumes of biological data and generate meaningful visual insights. High-performance computing (HPC) platforms and cloud-based visualization tools are further enhancing the accessibility and scalability of biological data analysis, allowing researchers to collaborate on global projects in real time. The integration of AI-driven algorithms in data visualization software is enabling automated pattern recognition and predictive modeling, helping researchers identify critical biological trends and relationships faster. These advancements are transforming the way scientists analyze biological data, facilitating more accurate and efficient drug discovery, genomics research, and personalized medicine initiatives.

Why Is Biological Data Visualization Becoming Essential in Life Sciences?

Biological data visualization is becoming increasingly essential in the life sciences, where the volume and complexity of data generated by modern research techniques are growing exponentially. Genomics, proteomics, and metabolomics research, as well as drug discovery, generate vast amounts of data that require sophisticated visualization techniques to uncover meaningful insights. By representing complex biological data in a graphical format, visualization tools enable researchers to identify patterns, relationships, and anomalies that would be difficult to detect through raw data alone. This is particularly important in genomics, where visual tools are used to map and compare genetic sequences, and in proteomics, where researchers can visualize protein structures and interactions. Additionally, biological data visualization is playing a critical role in the development of personalized medicine, where patient-specific data must be analyzed to tailor treatments to individual genetic profiles. As the life sciences field continues to advance, biological data visualization is becoming indispensable for unlocking new discoveries and accelerating scientific progress.

How Are Industry and Healthcare Trends Shaping the Biological Data Visualization Market?

The biological data visualization market is being shaped by several key trends in the healthcare and life sciences industries, particularly the increasing focus on personalized medicine and the rise of multi-omics research. As personalized medicine continues to gain traction, the need for sophisticated data visualization tools is becoming more pronounced. Researchers and clinicians must analyze large, complex datasets-such as genomic sequences, proteomic profiles, and clinical records-to identify unique biomarkers and develop tailored therapies for individual patients. This shift toward data-driven, personalized healthcare is driving demand for advanced biological data visualization solutions that can handle and interpret patient-specific data. Moreover, the growing adoption of multi-omics approaches, which integrate data from genomics, proteomics, transcriptomics, and metabolomics, is further increasing the complexity of biological data analysis. Visualization tools that can synthesize and display these multi-layered datasets in a coherent and interpretable manner are becoming critical for advancing research and improving clinical outcomes.

What Factors Are Driving Growth in the Biological Data Visualization Market?

The growth in the biological data visualization market is driven by several factors, including the increasing complexity of biological research, technological advancements in data analytics, and the expanding role of personalized medicine. One of the primary drivers is the rapid growth of genomics and multi-omics research, which generates vast amounts of data that require sophisticated visualization tools to analyze. The rise of AI and machine learning is also contributing to market growth, as these technologies enable the automation of data analysis and pattern recognition, making it easier for researchers to derive insights from complex biological data. Additionally, the growing focus on personalized medicine is driving demand for visualization tools that can help clinicians interpret patient-specific data and develop tailored treatment plans. The expansion of cloud computing and high-performance computing platforms is further enhancing the accessibility and scalability of biological data visualization solutions, enabling researchers to collaborate on large-scale projects and share insights globally. As the demand for data-driven research and personalized healthcare continues to rise, the biological data visualization market is expected to experience sustained growth.

SCOPE OF STUDY:

The report analyzes the Biological Data Visualization market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technique (Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography, Other Techniques); Application (Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis, Alignments, Phylogeny & Evolution, Systems Biology); End-Use (Academic Research, Pharma & Biotech Companies, Hospitals & Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â